Search

PROCEPT BioRobotics Corp

Geschlossen

BrancheGesundheitswesen

21.26 -7

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

21.01

Max

22.88

Schlüsselkennzahlen

By Trading Economics

Einkommen

-27M

-58M

Verkäufe

11M

94M

EPS

-0.47

Gewinnspanne

-61.905

Angestellte

888

EBITDA

5.1M

-24M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+6.54% upside

Dividenden

By Acuity

Nächstes Ergebnis

3. Nov. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

197M

1.2B

Vorheriger Eröffnungskurs

28.26

Vorheriger Schlusskurs

21.26

Nachrichtenstimmung

By Acuity

50%

50%

135 / 340 Ranking in Healthcare

PROCEPT BioRobotics Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Aug. 2026, 20:02 UTC

Procept Biorobotics Corp shares are higher today, marking the seventh consecutive session of gains. No specific news was identified to explain the increase.

10. Aug. 2026, 19:53 UTC

Procept Biorobotics Corp shares are higher, supported by reduced Fed rate hike expectations following Friday's weaker jobs report. The stock remains above its 20-day moving average.

7. Aug. 2026, 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6. Aug. 2026, 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5. Aug. 2026, 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4. Aug. 2026, 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3. Aug. 2026, 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31. Juli 2026, 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

30. Juli 2026, 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

29. Juli 2026, 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

28. Juli 2026, 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

27. Juli 2026, 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

22. Juli 2026, 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

21. Juli 2026, 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

20. Juli 2026, 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Peer-Vergleich

Kursveränderung

PROCEPT BioRobotics Corp Prognose

Kursziel

By TipRanks

6.54% Vorteil

12-Monats-Prognose

Durchschnitt 23.13 USD  6.54%

Hoch 29 USD

Tief 19 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für PROCEPT BioRobotics Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

11 ratings

3

Buy

7

Halten

1

Sell

Stimmung

By Acuity

135 / 340 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat